Abstract
The cover article “Advances in Breast Cancer Research” of a recent Harvard Women’s Health Watch exemplifies why much of breast cancer research remains controversial. Although the article begins, “In the last few months, breast cancer research appears to have undergone a climatic shift,” its content becomes restricted to two drugs for prevention (tamoxifen and raloxifene) and two for treatment (paclitaxel and Herceptin) of the disease (Robb-Nicholson 1998a). By reporting on drugs with side effects, such as increased risk of uterine cancer and blood clots, and with relatively small effects in preventing and treating the disease in certain high risk groups, this article typifies the biomedical approach to illness that characterizes breast cancer research.
Preview
Unable to display preview. Download preview PDF.
References
Altekruse, Joan M., and Sue V. Rosser. 1992. “Feminism and Medicine: Cooptation or Cooperation?” Pp. 27–40 in The Knowledge Explosion, ed. Cheris Kramarae and Dale Spender. New York: Teachers College Press.
Altman, Roberta. 1996. Waking Up/Fighting Back: The Politics of Breast Cancer. Boston: Little, Brown.
American Cancer Society 1999. “Breast Cancer Facts and Figures.” Atlanta, Ga.
Angell, Marcia. 1997. Science on Trial: The Clash of Medical Evidence and the Law in the Breast Implant Case. New York: W.W. Norton.
Armstrong, B., and Richard Doll. 1975. “Environmental Factors and Cancer Incidence and Mortality in Different Countries, with Special Reference to Dietary Practice.” International Journal of Cancer 15:617–31.
Bailar, John C., and Elaine Smith. 1986. “Progress Against Cancer?” New England Journal of Medicine 8:1226–32.
Batt, Sharon. 1994. The Politics of Breast Cancer. Charlottetown, P. E. I, Canada: Gynergy Books.
Begg, C. B. 1988. “Selection of Patients for Clinical Trials.” Seminars in Oncology 15:434.
Birke, Lynda. 1986. Women, Feminism, and Biology. New York: Methuen.
Bleier, Ruth. 1984. Science and Gender: A Critique of Biology and its Theories on Women. New York: Pergamon Press.
Bleier, Ruth. 1986. “Sex Differences Research: Science or Belief?” Pp. 147–64 in Feminist Approaches to Science, ed. Ruth Bleier. New York: Pergamon Press.
Boston Women’s Health Book Collective. 1973. Our Bodies, Ourselves. New York: Simon & Schuster.
Buell, P. 1973. “Changing Incidence of Breast Cancer in Japanese-American Women.” Journal of the National Cancer Institute 51:1479–1783.
Charney, Pamela, and Carole Morgan. 1996. “Do Treatment Recommendations Reported in the Research Literature Consider Differences Between Women and Men?” Journal of Women’s Health 5(6):579–84.
Department of Defense. 2000. Breast Cancer Research Program, Program Announcement. U.S. Army Medical Research and Materiel Command. Fort Detrick, Md.
Dowie, Mark, and Tracy Johnston. 1977. “A Case of Corporate Malpractice and the Dalkon Shield.” Pp. 89–104 in Seizing Our Bodies, ed. Claudia Dreifus. New York: Vintage Books.
Fausto-Sterling, Anne. 1992. Myths of Gender. New York: Basic Books.
Fee, Elizabeth. 1981. “Is Feminism a Threat to Scientific Objectivity?” International Journal of Women’s Studies 4:213–33.
Fee, Elizabeth. 1982. “A Feminist Critique of Scientific Objectivity.” Science for the People 14(4):8.
Fisher, Bernard, Carol Redmond, Leslie Ford, and Susan Nayfield. 1992. “Investigators of the Breast Cancer Prevention Trial Reply.” New England Journal of Medicine 327(22): 1596–97.
Fletcher, Suzanne. 1997. “Whither Scientific Deliberation in Health Policy Recommendations: Alice in the Wonderland of Breast-Cancer Screening.” New England Journal of Medicine 336(16): 1180–83.
Fugh-Berman, Adriane, and Samuel Epstein. 1992. “Should Healthy Women Take Tamoxifen?” New England Journal of Medicine 327(22):1596.
Goodwin, J. S., W. C. Hunt, C. R. Key, and J. M. Samet. 1988. “Cancer Treatment Protocols: Who Gets Chosen?” Archives of Internal Medicine 148:2258.
Grobbee, D. E., E. B. Rimm, E. Giovannucci, G. Colditz, M. Stampfer, and W. Willett. 1990. “Coffee, Caffeine, and Cardiovascular Disease in Men.” New England Journal of Medicine 321:1026–32.
Gurwitz, J. H., F. C. Nananda, and J. Avorn. 1992. “The Exclusion of the Elderly and Women from Clinical Trials in Acute Myocardial Infarction.” Journal of the American Medical Association 268(2):1417–22.
Hamilton, Jean. 1985. “Avoiding Methodological Biases in Gender-Related Research.” In Women’s Health Report of the Public Health Task Force on Women’s Health Issues. Washington, D.C: U.S. Department of Health and Human Services.
Haraway, Donna. 1978. “Animal Sociology and a Natural Economy of the Body Politic, Part I: A Political Physiology of Dominance;” and “Animal Sociology and a Natural Economy of the Body Politic, Part II: The Past is the Contested Zone: Human Nature and Theories of Production and Reproduction in Primate Behavior Studies.” Signs: Journal of Women in Culture and Society 4(1):21–60.
Haraway, Donna. 1989. “Monkeys, Aliens, and Women: Love, Science, and Politics at the Intersection of Feminist Theory and Colonial Discourse.” Women’s Studies International Forum 12(3):295–312.
Haraway, Donna. 1997. Modest_Witness@Second_Millenium: Femaleman⊕ Meets Oncomouse:™ Feminism and Technoscience. New York: Routledge.
Harding, Sandra. 1986. The Science Question in Feminism. Ithaca: Cornell University Press.
Harding, Sandra. 1993. The “Racial” Economy of Science: Toward a Democratic Future. Bloomington: Indiana University Press.
Harding, Sandra. 1998. Is Science Multicultural? Bloomington: Indiana University Press.
Healy, Bernadine. 1991. “Women’s Health, Public Welfare.” Journal of the American Medical Association 264(4):566–68.
Herman, Robin. 1994. “Tamoxifen on Trial.” Washington Post (September 23) 9–10.
Hrushesky, William. 1996. “Breast Cancer, Timing of Surgery, and the Menstrual Cycle: Call for Prospective Trial.” Journal of Women’s Health 5(6):555–66.
Hrushesky, William, A. Z. Bluming, S. A. Gruber, and R. B. Sothern. 1989. “Menstrual Influence on Surgical Cure of Breast Cancer.” Lancet 2:949.
Hubbard, Ruth. 1990. Politics of Women’s Biology. New Brunswick: Rutgers University Press.
Hunter, C. P. 1989. “Cancer Control and the Community Oncology Programs: Minority Participation in the National Cancer Institute Clinical Trials Network.” P. 94 in Minorities and Cancer, ed. L. A. Jones. New York: Springer-Verlag.
Jaggar, Alison M. 1983. Feminist Politics and Human Nature. Totowa, N.J.: Rowman and Allanheld.
Keller, Evelyn Fox. 1982. “Feminism and Science.” Signs 7(3):589–602.
Harding, Sandra. 1983. A Feeling for the Organism: The Life and Work of Barbara McClintock. New York: W. H. Freeman.
Harding, Sandra. 1985. Reflections on Gender and Science. New Haven: Yale University Press.
Harding, Sandra. 1992. Secrets of Life, Secrets of Death. New York: Routledge.
King, Mary-Claire, Sara Rowell, and Susan M. Love. 1993. “Inherited Breast and Ovarian Cancer: What Are the Risks? What Are the Choices?” Journal of the American Medical Association 269(15): 1975–80.
Kuhn, Thomas S. 1970. The Structure of Scientific Revolutions. 2d ed. Chicago: University of Chicago Press.
Lerman, C., M. Daly, A. Masny, and A. Balshem. 1994. “Attitudes about Genetic Testing for Breast-Ovarian Cancer Susceptibility.” Journal of Clinical Oncology 12:843–50.
Lippman, Mark, and Bruce Chabner. 1986. “Editorial Overview of NIH Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer.” National Cancer Institute Monograph 1. Bethesda, MD: National Institutes of Health.
Longino, Helen. 1990. Science as Social Knowledge: Values and Objectivity in Scientific Inquiry. Princeton: Princeton University Press.
Love, Susan M. 1990. Dr. Susan Love’s Breast Book. New York: Addison-Wesley.
Marwick, Charles. 1997. “Final Mammography Recommendation.” Journal of the American Medical Association 277(15): 1181.
McLeod, S. 1987. Scientific Colonialism: A Cross-Cultural Comparison. Washington, D.C.: Smithsonian Institution Press.
Multiple Risk Factor Intervention Trial Research Group. 1990. “Mortality Rates After 10.5 Years for Participants in the Multiple Risk Factor Intervention Trial: Findings Related to a Prior Hypothesis of the Trial.” Journal of the American Medical Association 263:1795.
National Breast Cancer Coalition (NBCC). 1997. “Legislative Update.” Call to Action 4(3–4):6–8.
National Breast Cancer Coalition (NBCC). 1998. “Campaign: Vote Breast Cancer.” 1998 Voting Record 2 5(1):2.
Norwood, Chris. 1988. “Alarming Rise in Deaths.” Ms. (July) 65–67.
Paskett, Electra D., Hyman B. Muss, L. Douglas Case, and M. Robert Cooper. 1996. “Participation in Clinical Treatment Trials: Factors Affecting Participation for Women with Breast Cancer.” Journal of Women’s Health 5(6):585–92.
Raloff, Janet. 1994. “Tamoxifen Turmoil: New Issues Emerge as Healthy Women Volunteer to Take Potent Drug.” Science News 146(17):268–69.
Robb-Nicholson, Celeste. 1998a. “Advances in Breast Cancer Research.” Harvard Women’s Health Watch V(11):1–2.
Robb-Nicholson 1998b. “New Studies Question Tamoxifen’s Benefits.” Harvard Women’s Health Watch VI(1):7.
Rosser, Sue V. 1986. Teaching Science and Health from a Feminist Perspective: A Practical Guide. Elmsford, N.Y.: Pergamon Press.
Rosser, Sue V. 1988. “Women in Science and Health Care: A Gender at Risk.” Pp. 3–15 in Feminism Within the Science of Health Care Professions: Overcoming Resistance, ed. Sue V. Rosser. Elmsford, N.Y.: Pergamon Press.
Rosser, Sue V. 1994. Women’s Health: Missing from U.S. Medicine. Bloomington: Indiana University Press.
Rosser, Sue V. 1997. “The Next Millennium is Here Now: Women’s Studies Perspectives on Biotechnics and Reproductive Technologies.” Transformations 8(1): 1–27.
Rubin, Rita. 1998. “FDA Panel Oks Two Breast Cancer Drugs.” USA Today (September 3) ID, 5D.
Scully, Diana, and Pauline Bart. 1973. “A Funny Thing Happened on the Way to the Orifice: Women in Gynecology Textbooks.” American Journal of Sociology 78:1045.
Seaman, Barbara, and Gideon Seaman. 1977. Women and the Crisis in Sex Hormones. New York: Rawson.
Senie, R., P. Rosen, P. Rhondes, and M. Lesser. 1991. “Timing of Breast Cancer Excision During the Menstrual Cycle Influences Duration of Disease-Free Survival.” Annals of Internal Medicine 115:337.
Spanier, Bonnie. 1995. Impartial Science: Gender Ideology in Molecular Biology. Bloomington: Indiana University Press.
Steering Committee of the Physician’s Health Study Group. 1989. “Final Report on the Aspirin Component of the Ongoing Physician’s Health Study.” New England Journal of Medicine 321:129–35.
Taylor, C. 1994. “Gender Equity in Research.” Journal of Women’s Health 3:143–53.
U.S. Department of Health and Human Services. National Institutes of Health. 1994. “NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research; Notice.” Federal Register 59:14508–15413.
Yancik, R., S. G. Ries, and J. W. Yates. 1989. “Breast Cancer in Aging Women: A Population-Based Study of Contrasts in Stage, Surgery, and Survival.” Cancer 63:976.
Zimmerman, B., et al. 1980. “People’s Science.” Pp. 299–319 in Science and Liberation, ed. Rita Arditti, Pat Brennan, and Steve Cavrak. Boston: South End Press.
Copyright information
© 2000 Anne S. Kasper, Susan J. Ferguson
About this chapter
Cite this chapter
Rosser, S.V. (2000). Controversies in Breast Cancer Research. In: Breast Cancer. Palgrave Macmillan, New York. https://doi.org/10.1007/978-1-137-03779-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-137-03779-4_9
Publisher Name: Palgrave Macmillan, New York
Print ISBN: 978-0-312-29451-9
Online ISBN: 978-1-137-03779-4
eBook Packages: Palgrave History CollectionHistory (R0)